Trial intelligence / Profile preview

OPC-41061 in Cardiac Edema

NCT00525265Phase 3Completed

Sponsor
Otsuka Pharmaceutical Co., Ltd.
Start
Sep 2007
Primary completion
Jan 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of tolvaptan in edema secondary to heart failure, sponsored by Otsuka Pharmaceutical Co., Ltd.. Started Sep 2007; status: completed.

02

Drugs

tolvaptan
03

Conditions

edema secondary to heart failure

Beyond the preview

Go deeper on NCT00525265.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00525265.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call